Sensex, Nifty, Share Prices LIVE: The short-term outlook is bullish for Mankind Pharma. The stock has been rising very well since the last week of June. The 4 per cent rise this week has taken the share price well above a key resistance level of ₹2,465. The region between ₹2,480 and ₹2,460 will now act as a good support zone. Intermediate dips are likely to be limited to this support zone. Mankind Pharma’s share price can rise to ₹2,670 in the coming weeks. Traders can buy Mankind Pharma shares now at ₹2,543.
